These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 23574177)
1. Innate immunity in Alzheimer's disease: a complex affair. Guillot-Sestier MV; Town T CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):593-607. PubMed ID: 23574177 [TBL] [Abstract][Full Text] [Related]
2. Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits. Scholtzova H; Do E; Dhakal S; Sun Y; Liu S; Mehta PD; Wisniewski T J Neurosci; 2017 Jan; 37(4):936-959. PubMed ID: 28123027 [TBL] [Abstract][Full Text] [Related]
3. TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease. Song M; Jin J; Lim JE; Kou J; Pattanayak A; Rehman JA; Kim HD; Tahara K; Lalonde R; Fukuchi K J Neuroinflammation; 2011 Aug; 8():92. PubMed ID: 21827663 [TBL] [Abstract][Full Text] [Related]
4. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Streit WJ; Braak H; Xue QS; Bechmann I Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731 [TBL] [Abstract][Full Text] [Related]
5. Microglia and inflammation in Alzheimer's disease. Mandrekar-Colucci S; Landreth GE CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):156-67. PubMed ID: 20205644 [TBL] [Abstract][Full Text] [Related]
6. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models. Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S Elife; 2020 Jun; 9():. PubMed ID: 32510331 [TBL] [Abstract][Full Text] [Related]
7. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease. Webers A; Heneka MT; Gleeson PA Immunol Cell Biol; 2020 Jan; 98(1):28-41. PubMed ID: 31654430 [TBL] [Abstract][Full Text] [Related]
11. Manipulation of microglial activity as a therapy for Alzheimer's disease. Tan B; Choi RH; Chin TJ; Kaur C; Ling EA Front Biosci (Schol Ed); 2012 Jun; 4(4):1402-12. PubMed ID: 22652882 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease. Mori T; Koyama N; Arendash GW; Horikoshi-Sakuraba Y; Tan J; Town T Glia; 2010 Feb; 58(3):300-14. PubMed ID: 19705461 [TBL] [Abstract][Full Text] [Related]
13. Microglial modulation as a therapeutic strategy in Alzheimer's disease: Focus on microglial preconditioning approaches. Yassaghi Y; Nazerian Y; Ghasemi M; Nazerian A; Sayehmiri F; Perry G; Gholami Pourbadie H J Cell Mol Med; 2024 Aug; 28(15):e18554. PubMed ID: 39103747 [TBL] [Abstract][Full Text] [Related]
14. The antimicrobial protection hypothesis of Alzheimer's disease. Moir RD; Lathe R; Tanzi RE Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800 [TBL] [Abstract][Full Text] [Related]
15. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide. Townsend KP; Town T; Mori T; Lue LF; Shytle D; Sanberg PR; Morgan D; Fernandez F; Flavell RA; Tan J Eur J Immunol; 2005 Mar; 35(3):901-10. PubMed ID: 15688347 [TBL] [Abstract][Full Text] [Related]
16. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease. Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597 [TBL] [Abstract][Full Text] [Related]
17. Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease. Cameron B; Tse W; Lamb R; Li X; Lamb BT; Landreth GE J Neurosci; 2012 Oct; 32(43):15112-23. PubMed ID: 23100432 [TBL] [Abstract][Full Text] [Related]
18. The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease. Minter MR; Taylor JM; Crack PJ J Neurochem; 2016 Feb; 136(3):457-74. PubMed ID: 26509334 [TBL] [Abstract][Full Text] [Related]
19. The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function. Marsh SE; Abud EM; Lakatos A; Karimzadeh A; Yeung ST; Davtyan H; Fote GM; Lau L; Weinger JG; Lane TE; Inlay MA; Poon WW; Blurton-Jones M Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1316-25. PubMed ID: 26884167 [TBL] [Abstract][Full Text] [Related]
20. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. Fiala M; Lin J; Ringman J; Kermani-Arab V; Tsao G; Patel A; Lossinsky AS; Graves MC; Gustavson A; Sayre J; Sofroni E; Suarez T; Chiappelli F; Bernard G J Alzheimers Dis; 2005 Jun; 7(3):221-32; discussion 255-62. PubMed ID: 16006665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]